6901 — Diamond Biofund Income Statement
0.000.00%
Last trade - 00:00
- TWD34.27bn
- TWD27.58bn
- -TWD2.44bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | -303 | 6,501 | 3,064 | 1,016 | -2,440 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 64.5 | 404 | 102 | 138 | 162 |
Operating Profit | -368 | 6,097 | 2,961 | 878 | -2,602 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -371 | 6,091 | 2,961 | 881 | -2,584 |
Provision for Income Taxes | |||||
Net Income After Taxes | -371 | 6,090 | 2,852 | 798 | -2,583 |
Net Income Before Extraordinary Items | |||||
Net Income | -371 | 6,090 | 2,852 | 798 | -2,583 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -371 | 6,090 | 2,852 | 798 | -2,583 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.495 | 8.13 | 3.81 | 1.03 | -3.32 |
Dividends per Share |